Melanoma

Melanoma, the most serious type of skin cancer, develops in the cells (melanocytes) that produce melanin – the pigment that gives skin its color. It can also occur in the eyes and, rarely, inside the body, such as in the nose or throat. Reducing exposure to UV radiation can help lower the risk of melanoma. The risk of melanoma seems to increase in people over 40, and especially in women.

Showing 1–12 of 17 results

Filter our product list:

Product Batch	Antigen	Molecular Class	Drug Brand	Product Concentration	CoA	Quantity per vial	Storage Temperature	Expiry Date	Price from
Aldesleukin M003854	IL-2RB	Recombinant protein	Proleukin®	1,1 mg/mL	–	0,044 mg	-80°C	2026.01	347,00 €	view product Max: 10 Min: 1 Step: 1
Ipilimumab 8010125	CTLA-4	Monoclonal Antibody	Yervoy®	5 mg/mL	yes	2 mg	-80°C	2024.09	874,00 €	view product Max: 8 Min: 1 Step: 1
Ipilimumab ABE0468	CTLA-4	Monoclonal Antibody	Yervoy®	5 mg/mL	yes	2 mg	-80°C	2021.08	874,00 €	view product Max: 1 Min: 1 Step: 1
Nivolumab 8038581	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	2025.05	316,00 €	view product Max: 2 Min: 1 Step: 1
Nivolumab 8039750	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	2025.03	316,00 €	view product Max: 10 Min: 1 Step: 1
Nivolumab AAN6970	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	2018.08	316,00 €	view product Max: 10 Min: 1 Step: 1
Nivolumab AAP6351	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	2018.10	316,00 €	view product Max: 10 Min: 1 Step: 1
Nivolumab AAQ3795	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	2018.02	316,00 €	view product Max: 10 Min: 1 Step: 1
Nivolumab AAU3964	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	2019.05	316,00 €	view product Max: 5 Min: 1 Step: 1
Nivolumab AAW0883	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	2019.01	316,00 €	view product Max: 10 Min: 1 Step: 1
Nivolumab AAW6409	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	2020.09	316,00 €	view product Max: 5 Min: 1 Step: 1
Nivolumab AAX0742	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	2020.11	316,00 €	view product Max: 7 Min: 1 Step: 1
Pembrolizumab 6302603D04	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	2018.07	528,00 €	view product Max: 7 Min: 1 Step: 1
Pembrolizumab 7302601E01	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	2018.12	528,00 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab 7302607002	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	2019.03	528,00 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab 7302613A05	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	2019.07	528,00 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab Y010734	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	2025.10	528,00 €	view product Max: 3 Min: 1 Step: 1

Not looking for Melanoma?

Search our therapeutic molecules product database